Where could AIDX trade next? Consensus target price: $5.
Get informed when a big investor buys or sells
+ Follow$0.44
1 analysts in the last 4 months
High: $5 | Low: $5
No recommendations in the last 4 months.
As of the most recent data, AIDX shows a target price of $5. Scroll down for historical charts and peer comparison views.
If 20/20 Biolabs Common Stock moved to the average analyst target of $5, shares would be roughly 1033.0% higher than $0.44. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of 20/20 Biolabs Common Stock's earnings trajectory.
Besides this target price page, Stockcircle has 20/20 Biolabs Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $5) with ownership activity and broader fundamentals.